Earnings Call · Q2 FY2021·2021-08-10

Q2 21EPS -30.61%·Rev n/aQ1 21EPS -59.38%·Rev n/aQ4 20EPS 0.00%·Rev n/aQ3 20EPS +8.11%·Rev n/a⚠ consensus missing

aTYR PHARMA INC ATYR

Ashlee Dunston — Investor Relations

Sanjay Shukla — President and Chief Executive Officer

Jill Broadfoot — Chief Financial Officer

+0.8%1d on move date+0.6% vs SPY3d+0.6%5d−2.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ATYR calls or request research access.

More ATYR calls Browse calls Request research access